Learn More
Medchemexpress LLC 4-[(5,5-dimethyl-8-quinolin-3-yl-6H-naphthalene-2-carbonyl)amino]benzoic acid | 182135-66-6 | MFCD00952209 | 99.5% | 448.50 g/mol | C29H24N2O3 | 50 MG

Supplier: Medchemexpress LLC HY10125950MG
A neutral, RARα-selective antagonist used as a research reagent to modulate retinoic acid receptor alpha signaling in biochemical and cell-based studies. It is supplied as a high-purity powder suitable for analytical and biological assays, with reported activity in inflammatory and angiogenic pathways and effects on cell migration and phototoxicity.
- High affinity for RARα receptor, enabling receptor-specific studies
- High purity suitable for analytical and biological assays
- Powder form allows flexible dosing and formulation
- Demonstrated modulation of inflammatory signaling pathways
- Applicable to studies of phototoxicity, angiogenesis, and cell migration
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.